Meet Ken Mulvany, Founder and Chairman of BenevolentAI at the 12th Annual Meeting of the New Champions.
The World Economic Forum is the de facto International Organisation for Public-Private Cooperation. It engages the foremost political, business and other leaders of society to shape global, regional and industry agendas.
We are excited to be named this year as a Technology Pioneer by the World Economic Forum - and over the next two years, BenevolentAI will help shape and contribute towards the Forum’s initiatives, helping to positively transform society and industry.
Our first activity as a Pioneer will be for our founder and Chairman Ken Mulvany to participate in the World Economic Forum Annual Meeting of the New Champions, held in Tianjin, China, September 18-20.
Ken is a serial entrepreneur, investor and healthcare and technology veteran with more than 20 years of business leadership experience. He was previously CEO of Proximagen, a UK-based biotech company committed to delivering novel drugs and innovative new treatments for central nervous system (CNS) disorders. Following the acquisition of this business, Ken began to think deeply about the drug discovery landscape. He founded BenevolentAI with two very specific ambitions: firstly, to build a technology that could ingest all of the world's available bioscience information, and secondly, to create a “thinking” technology to reason on all of that data, making new knowledge available to scientists and their research